Factor H potentiating antibodies and uses thereof
US11820814B2 · kind B2 · utility
0Cited by
4References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 17, 2020 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Jul 17, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.